A detailed history of Us Bancorp \De\ transactions in Abbott Laboratories stock. As of the latest transaction made, Us Bancorp \De\ holds 3,045,301 shares of ABT stock, worth $342 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
3,045,301
Previous 3,066,979 0.71%
Holding current value
$342 Million
Previous $319 Million 8.94%
% of portfolio
0.45%
Previous 0.44%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$100.07 - $118.13 $2.17 Million - $2.56 Million
-21,678 Reduced 0.71%
3,045,301 $347 Million
Q2 2024

Aug 06, 2024

SELL
$100.73 - $112.44 $3.47 Million - $3.88 Million
-34,482 Reduced 1.11%
3,066,979 $319 Million
Q1 2024

May 07, 2024

SELL
$109.52 - $120.96 $677,600 - $748,379
-6,187 Reduced 0.2%
3,101,461 $353 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $1.9 Million - $2.33 Million
-21,088 Reduced 0.67%
3,107,648 $342 Million
Q3 2023

Nov 03, 2023

SELL
$95.53 - $114.62 $415,842 - $498,940
-4,353 Reduced 0.14%
3,128,736 $303 Million
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $3.21 Million - $3.57 Million
-31,830 Reduced 1.01%
3,133,089 $342 Million
Q1 2023

May 09, 2023

SELL
$96.86 - $114.01 $2.44 Million - $2.87 Million
-25,197 Reduced 0.79%
3,164,919 $320 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $21.3 Million - $25 Million
224,181 Added 7.56%
3,190,116 $350 Million
Q3 2022

Oct 27, 2022

SELL
$96.76 - $112.03 $4.16 Million - $4.82 Million
-43,043 Reduced 1.43%
2,965,935 $287 Million
Q2 2022

Aug 01, 2022

SELL
$102.07 - $123.37 $971,093 - $1.17 Million
-9,514 Reduced 0.32%
3,008,978 $327 Million
Q1 2022

May 11, 2022

BUY
$114.02 - $139.04 $2.82 Million - $3.44 Million
24,716 Added 0.83%
3,018,492 $357 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $1.49 Million - $1.82 Million
12,860 Added 0.43%
2,993,776 $421 Million
Q3 2021

Nov 10, 2021

SELL
$116.66 - $129.06 $717,109 - $793,331
-6,147 Reduced 0.21%
2,980,916 $352 Million
Q2 2021

Aug 05, 2021

SELL
$105.79 - $124.53 $4.77 Million - $5.62 Million
-45,117 Reduced 1.49%
2,987,063 $346 Million
Q1 2021

Apr 28, 2021

SELL
$108.84 - $128.23 $1.18 Million - $1.4 Million
-10,879 Reduced 0.36%
3,032,180 $363 Million
Q4 2020

Feb 04, 2021

BUY
$105.0 - $114.42 $440,580 - $480,106
4,196 Added 0.14%
3,043,059 $333 Million
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $3.05 Million - $3.7 Million
33,257 Added 1.11%
3,038,863 $331 Million
Q2 2020

Aug 07, 2020

BUY
$76.57 - $98.0 $67,764 - $86,730
885 Added 0.03%
3,005,606 $275 Million
Q1 2020

May 13, 2020

BUY
$62.82 - $91.86 $5.03 Million - $7.35 Million
80,027 Added 2.74%
3,004,721 $237 Million
Q4 2019

Feb 04, 2020

SELL
$78.51 - $87.4 $5.9 Million - $6.57 Million
-75,175 Reduced 2.51%
2,924,694 $254 Million
Q3 2019

Nov 08, 2019

SELL
$81.84 - $88.74 $12 Million - $13.1 Million
-147,107 Reduced 4.67%
2,999,869 $251 Million
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $5.48 Million - $6.4 Million
-75,242 Reduced 2.34%
3,146,976 $265 Million
Q1 2019

May 08, 2019

SELL
$66.22 - $80.06 $6.77 Million - $8.19 Million
-102,293 Reduced 3.08%
3,222,218 $258 Million
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $1.43 Million - $1.62 Million
-21,835 Reduced 0.65%
3,324,511 $240 Million
Q3 2018

Nov 01, 2018

BUY
$60.81 - $73.36 $18.3 Million - $22.1 Million
301,254 Added 9.89%
3,346,346 $245 Million
Q2 2018

Aug 08, 2018

SELL
$57.57 - $63.54 $3.02 Million - $3.33 Million
-52,381 Reduced 1.69%
3,045,092 $186 Million
Q1 2018

May 08, 2018

SELL
$56.27 - $63.62 $3.84 Million - $4.35 Million
-68,315 Reduced 2.16%
3,097,473 $186 Million
Q4 2017

Feb 02, 2018

SELL
$53.68 - $57.47 $2.02 Million - $2.16 Million
-37,625 Reduced 1.17%
3,165,788 $181 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $154 Million - $172 Million
3,203,413
3,203,413 $171 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.